- Home
- SNY vs SMFG Comparison
SNY vs SMFG Comparison
Compare SNY & SMFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- SMFG
- Stock Information
- Founded
- SNY 1994
- SMFG 2002
- Country
- SNY France
- SMFG Japan
- Employees
- SNY N/A
- SMFG N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- SMFG Commercial Banks
- Sector
- SNY Health Care
- SMFG Finance
- Exchange
- SNY Nasdaq
- SMFG Nasdaq
- Market Cap
- SNY 116.5B
- SMFG 96.4B
- IPO Year
- SNY N/A
- SMFG 1949
- Fundamental
- Price
- SNY $47.43
- SMFG $15.87
- Analyst Decision
- SNY Hold
- SMFG
- Analyst Count
- SNY 1
- SMFG 0
- Target Price
- SNY $65.00
- SMFG N/A
- AVG Volume (30 Days)
- SNY 2.3M
- SMFG 2.1M
- Earning Date
- SNY 07-31-2025
- SMFG 07-31-2025
- Dividend Yield
- SNY 3.37%
- SMFG 2.51%
- EPS Growth
- SNY 118.56
- SMFG N/A
- EPS
- SNY 8.65
- SMFG 0.86
- Revenue
- SNY $53,714,621,258.00
- SMFG $23,194,711,070.00
- Revenue This Year
- SNY $2.85
- SMFG $39.22
- Revenue Next Year
- SNY $6.65
- SMFG $3.98
- P/E Ratio
- SNY $5.49
- SMFG $29.76
- Revenue Growth
- SNY 15.65
- SMFG N/A
- 52 Week Low
- SNY $44.73
- SMFG $11.73
- 52 Week High
- SNY $60.12
- SMFG $16.74
- Technical
- Relative Strength Index (RSI)
- SNY 43.53
- SMFG 59.72
- Support Level
- SNY $46.14
- SMFG $15.10
- Resistance Level
- SNY $47.54
- SMFG $15.75
- Average True Range (ATR)
- SNY 0.81
- SMFG 0.19
- MACD
- SNY -0.17
- SMFG 0.02
- Stochastic Oscillator
- SNY 38.54
- SMFG 58.93
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About SMFG Sumitomo Mitsui Financial Group Inc Unsponsored (Japan)
Sumitomo Mitsui Financial Group is roughly tied with Mizuho Financial Group for the status of Japan's second-largest bank after Mitsubishi UFJ Financial Group. As of March 2024, its market share of domestic loans was 7.2%, compared with 8.0% for MUFG. It has a larger consumer finance business than the other two megabanks, owning 100% of the Promise business and SMBC Card. It also controls one of Japan's largest leasing companies and SMBC Aviation Capital, one of the top five aircraft lessors globally. In securities, its SMBC Nikko unit is Japan's third-largest retail broker, although SMFG has lagged somewhat in institutional securities business and asset management.